You can buy or sell ASND and other stocks, options, ETFs, and crypto commission-free!
Ascendis Pharma A/S American Depositary Shares, also called Ascendis Pharma, is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a pipeline of sustained release prodrug therapies including endocrinology product candidates to support the market. Read More The company was founded by Jan Moller Mikkelsen and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
Hellerup, Capital Region
52 Week High
52 Week Low
Seeking AlphaMay 20
Ascendis Pharma's TransCon shows favorable safety profile in late-stage study
Preliminary data from a Phase 3 clinical trial, fliGHt, evaluating the safety and tolerability of Ascendis Pharma's (NASDAQ:ASND) TransCon Growth Hormone in patients with pediatric growth hormone deficiency previously treated with commercially available daily growth hormone therapies showed a comparable safety profile.
Yahoo FinanceMay 6
What You Must Know About Ascendis Pharma A/S's (NASDAQ:ASND) Financial Health
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Ascendis Pharma A/S (NASDAQ:ASND) with a market-capitalization of US$5.7b, rarely draw their attention. However, history shows that overlooked mid-cap companies have performed better on a risk-adjusted manner than the smaller and larger segment of the market. Today we will look at ASND’s fin...
-$0.85 per share